(Reuters) -Hinge Health and its selling stockholders raised $437.3 million in its U.S. initial public offering, the digital health startup said on Wednesday, after pricing its shares at the higher end of the marketed range. The company sold about 8.52 million shares and its shareholders, which include its largest investor, Insight Partners, sold 5.14 million […]
Health
Hinge Health, shareholders raise $437.3 million in US IPO
Audio By Carbonatix
(Reuters) -Hinge Health and its selling stockholders raised $437.3 million in its U.S. initial public offering, the digital health startup said on Wednesday, after pricing its shares at the higher end of the marketed range.
The company sold about 8.52 million shares and its shareholders, which include its largest investor, Insight Partners, sold 5.14 million shares at $32 per share, compared with its marketed range of $28 to $32 apiece.
Even at the top of its proposed range, Hinge Health’s target is nearly 52% lower than its $6.2 billion valuation from the 2021 Series E round, led by Coatue Management and Tiger Global.
The company will list on the New York Stock Exchange on Thursday, under the symbol ‘HNGE’.
Morgan Stanley, Barclays Capital and BofA Securities are the lead underwriters for the offering.
Founded in 2014 by Daniel Perez and Gabriel Mecklenburg, Hinge Health’s platform leverages artificial intelligence to provide at-home musculoskeletal care, chronic pain management, and post-surgical rehabilitation.
De-escalation in the U.S.-China trade tensions has helped in the revival of the IPO market, which saw a period of subdued activity in early 2025.
(Reporting by Jaiveer Singh Shekhawat, Pritam Biswas and Devika Nair in Bengaluru; Editing by Vijay Kishore and Shreya Biswas)